Coronavirus (COVID-19)

Over the course of the pandemic, racial disparities in cases and deaths have widened and narrowed. However, overall, Black, Hispanic, and American Indian and Alaska Native (AIAN) people have borne the heaviest health impacts of the pandemic. While Black and Hispanic people were less likely than their White counterparts to receive a vaccine during the initial phases of the vaccination rollout, these disparities have narrowed over time and reversed for Hispanic people.

This analysis examines the cost of COVID-19 treatment for inpatient care among people with health coverage through large employers. It finds that in 2020, COVID-19 hospitalizations cost an average of $41,611, including an average out-of-pocket payment of $1,280 for people with large employer coverage.

This updated analysis examines COVID-19’s effect on mortality rates, and estimates that in January 2022, COVID-19 was number two on the list of leading causes of death in the U.S.

This policy watch describes recent trends in children’s COVID-19 and routine vaccinations and explores strategies to increase vaccination rates among children as we head into the winter season.

This annual survey of employers provides a detailed look at trends in employer-sponsored health coverage, including premiums, worker contributions, cost-sharing provisions, offer rates, and more. This year’s report also looks at how employers are addressing a growing need for mental health services.

The COVID-19 pandemic has driven record rises in Medicaid enrollment and substantial increases in total Medicaid spending. The forthcoming end of the Public Health Emergency — and the subsequent unwinding of additional federal funding for Medicaid and the requirement for continuous coverage — are expected to increase state costs and…

A new KFF brief analyzes how the accessibility and cost of COVID-19 vaccines, treatments, and tests will change after the current government supply is depleted and the public health emergency ends. The Biden Administration has announced that it will have to end its purchase and distribution of COVID supplies as…

The era of government-financed COVID tests, vaccines, and therapeutics is likely coming to an end soon. In August, the Administration announced that by January 2023, it expects to end its purchase and distribution of COVID vaccines, citing a lack of federal funds. The announcement signals the shift in the United…

The covid-19 pandemic continues to cast a long shadow over the lives of older adults and their family caregivers in the United States, even as many Americans resolve to move on and resume normal activities. Even President Joe Biden declared “the pandemic is over,” in a recent interview, a controversial…

Although COVID-19 fatalities remain much lower than during the peak of last winter’s Omicron surge, deaths among people 65 and older spiked over the summer, more than doubling between April and July 2022, finds a new KFF analysis. The number of deaths topped more than 11,000 people 65 and older…